Liječnički vjesnik, Vol. 138 No. 7-8, 2016.
Stručni rad
CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY OF MEDICAL ONCOLOGY CLINICAL GUIDELINES Part II: renal cell cancer, urinary bladder cancer, prostate cancer, testicular cancer
Milena Gnjidić
Željko Vojnović
Mislav Čonkaš
Filip Grubišić Čabo
Borislav Belev
Anuška Budisavljević
Ivan Gilja
Natalija Dedić Plavetić
Robert Šeparović
Sažetak
The treatment of oncological patients must be based upon multidisciplinary approach, and takes place in specialized oncological centers. By the end of a specific oncological treatment further follow-up is being managed mostly by the oncologists, but the role of the general practitioners becomes more important every day and therefore should be precisely defined. Nowadays, most of the existing follow-up guidelines are not based on prospective studies, but on the experts opinion of individual oncological centers or specialists. The aim of the Croatian Society of Medical Oncology (CSMO) with these recommendations is to standardize and rationalize the diagnostic procedures algorithm in the follow–up of oncological patients after primary treatment, in patients with renal cell cancer, urinary bladder cancer, prostate cancer and testicular cancer.
Ključne riječi
Kidney neoplasms – diagnosis, pathology, therapy; Carcinoma, renal cell – diagnosis, pathology, therapy; Urinary bladder neoplasms – diagnosis, pathology, therapy; Prostatic neoplasms – diagnosis, pathology, therapy; Testicular neoplasms – diagnosis, pathology, therapy; Seminoma – diagnosis, pathology, therapy; Neoplasm staging; Medical oncology – standards; Practice guidelines as topic – standards; Follow-up studies; Croatia
Hrčak ID:
172865
URI
Datum izdavanja:
5.9.2016.
Posjeta: 2.276 *